Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2013, Article ID 410748, 11 pages
http://dx.doi.org/10.1155/2013/410748
Review Article

Responsiveness of Various Exercise-Testing Protocols to Therapeutic Interventions in COPD

1Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec City, QC, Canada
2Centre de Pneumologie, Institut Universitaire de Cardiologie et de Pneumologie de Québec, 2725 Chemin Sainte-Foy, Quebec City, QC, Canada G1V 4G5

Received 19 September 2012; Revised 3 December 2012; Accepted 4 December 2012

Academic Editor: Bruce D. Johnson

Copyright © 2013 Benoit Borel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. J. Martinez, G. Foster, J. L. Curtis et al., “Predictors of mortality in patients with emphysema and severe airflow obstruction,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 12, pp. 1326–1334, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Oga, K. Nishimura, M. Tsukino, S. Sato, and T. Hajiro, “Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 4, pp. 544–549, 2003. View at Google Scholar · View at Scopus
  3. J. Reardon, R. Casaburi, M. Morgan, L. Nici, and C. Rochester, “Pulmonary rehabilitation for COPD,” Respiratory Medicine, vol. 99, no. 2, pp. S19–S27, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. American Thoracic Society, “ATS/ACCP Statement on cardiopulmonary exercise testing,” American Journal of Respiratory and Critical Care Medicine, vol. 167, pp. 211–277, 2003. View at Google Scholar
  5. S. Bernard, F. Whittom, P. Leblanc et al., “Aerobic and strength training in patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 3, pp. 896–901, 1999. View at Google Scholar · View at Scopus
  6. J. J. W. Liesker, P. J. Wijkstra, N. H. T. Ten Hacken, G. H. Koéter, D. S. Postma, and H. A. M. Kerstjens, “A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD,” Chest, vol. 121, no. 2, pp. 597–608, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Pepin, L. Laviolette, C. Brouillard et al., “Significance of changes in endurance shuttle walking performance,” Thorax, vol. 66, no. 2, pp. 115–120, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Pepin, D. Saey, L. Laviolette, and F. Maltais, “Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation,” Journal of Chronic Obstructive Pulmonary Disease, vol. 4, no. 3, pp. 195–204, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Aguilaniu, “Impact of bronchodilator therapy on exercise tolerance in COPD,” International Journal of COPD, vol. 5, no. 1, pp. 57–71, 2010. View at Google Scholar · View at Scopus
  10. L. Laviolette, J. Bourbeau, S. Bernard et al., “Assessing the impact of pulmonary rehabilitation on functional status in COPD,” Thorax, vol. 63, no. 2, pp. 115–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. American Thoracic Society, “Dyspnea. Mechanisms, assessment, and management: a consensus statement,” in American Journal of Respiratory and Critical Care Medicine, vol. 159, pp. 321–340, 1999. View at Google Scholar
  12. H. Perrault, J. Baril, S. Henophy, A. Rycroft, J. Bourbeau, and F. Maltais, “Paced-walk and step tests to assess exertional dyspnea in COPD,” Journal of Chronic Obstructive Pulmonary Disease, vol. 6, no. 5, pp. 330–339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Jaeschke, J. Singer, and G. H. Guyatt, “Measurement of health status: ascertaining the minimal clinically important difference,” Controlled Clinical Trials, vol. 10, no. 4, pp. 407–415, 1989. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Make, “How can we assess outcomes of clinical trials: The MCID Approach,” Journal of Chronic Obstructive Pulmonary Disease, vol. 4, no. 3, pp. 191–194, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. G. R. Norman, J. A. Sloan, and K. W. Wyrwich, “Interpretation of changes in health-related quality of life the remarkable universality of half a standard deviation,” Medical Care, vol. 41, no. 5, pp. 582–592, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. T. E. Dolmage, K. Hill, R. A. Evans, and R. S. Goldstein, “Has my patient responded? Interpreting clinical measurements such as the 6-minute-walk test,” in American Journal of Respiratory and Critical Care Medicine, vol. 184, pp. 642–646, 2011. View at Google Scholar
  17. D. A. Redelmeier, A. M. Bayoumi, R. S. Goldstein, and G. H. Guyatt, “Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 4, pp. 1278–1282, 1997. View at Google Scholar · View at Scopus
  18. P. O. Astrand, K. Rodahl, H. A. Dahl, and S. B. Stromme, Textbook of Work Physiology : Physiological Bases of Exercise, Human Kinetic, Champaign, Ill, USA, 4th edition, 2003.
  19. Y. Lacasse, R. Goldstein, T. J. Lasserson, and S. Martin, “Pulmonary rehabilitation for chronic obstructive pulmonary disease,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD003793, 2006. View at Google Scholar · View at Scopus
  20. S. J. Butcher and R. L. Jones, “The impact of exercise training intensity on change in physiological function in patients with chronic obstructive pulmonary disease,” Sports Medicine, vol. 36, no. 4, pp. 307–325, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. K. Beauchamp, M. Nonoyama, R. S. Goldstein et al., “Interval versus continuous training in individuals with chronic obstructive pulmonary disease- a systematic review,” Thorax, vol. 65, no. 2, pp. 157–164, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. D. E. O'Donnell, T. Fluge, F. Gerken et al., “Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD,” European Respiratory Journal, vol. 23, no. 6, pp. 832–840, 2004. View at Google Scholar · View at Scopus
  23. T. Oga, K. Nishimura, M. Tsukino, T. Hajiro, A. Ikeda, and T. Izumi, “The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease: a comparison of three different exercise tests,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 6, pp. 1897–1901, 2000. View at Google Scholar · View at Scopus
  24. J. J. W. Liesker, V. Van De Velde, M. Meysman et al., “Effects of formoterol (Oxis Turbuhaler) and ipratropium on exercise capacity in patients with COPD,” Respiratory Medicine, vol. 96, no. 8, pp. 559–566, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. O. Akkoca Yildiz, Z. P. Onen, G. Demir, B. Eris Gulbay, S. Saryal, and G. Karabiyikoglu, “Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients?” Tuberkuloz ve Toraks, vol. 54, no. 2, pp. 105–113, 2006. View at Google Scholar · View at Scopus
  26. A. Ikeda, K. Nishimura, H. Koyama, N. Sugiura, and T. Izumi, “Oxitropium bromide improves exercise performance in patients with COPD,” Chest, vol. 106, no. 6, pp. 1740–1745, 1994. View at Google Scholar · View at Scopus
  27. A. Ikeda, K. Nishimura, H. Koyama, M. Tsukino, M. Mishima, and T. Izumi, “Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease,” Thorax, vol. 51, no. 1, pp. 48–53, 1996. View at Google Scholar · View at Scopus
  28. S. Jenkins, “Which is the best exercise test to assess therapeutic intervention in COPD?” Chronic Respiratory Disease, vol. 5, no. 1, pp. 3–5, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Hsia, R. Casaburi, A. Pradhan, E. Torres, and J. Porszasz, “Physiological responses to linear treadmill and cycle ergometer exercise in COPD,” European Respiratory Journal, vol. 34, no. 3, pp. 605–615, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. R. S. Mathur, S. M. Revill, D. D. Vara, R. Walton, and M. D. L. Morgan, “Comparison of peak oxygen consumption during cycle and treadmill exercise in severe chronic obstructive pulmonary disease,” Thorax, vol. 50, no. 8, pp. 829–833, 1995. View at Google Scholar · View at Scopus
  31. T. L. Griffiths, M. L. Burr, I. A. Campbell et al., “Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial,” Lancet, vol. 355, no. 9201, pp. 362–368, 2000. View at Google Scholar · View at Scopus
  32. S. J. Singh, D. L. Smith, M. E. Hyland, and M. D. L. Morgan, “A short outpatient pulmonary rehabilitation programme: immediate and longer term effects on exercise performance and quality of life,” Respiratory Medicine, vol. 92, no. 9, pp. 1146–1154, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. S. J. Deacon, E. E. Vincent, P. L. Greenhaff et al., “Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 3, pp. 233–239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. S. M. Revill, M. D. L. Morgan, S. J. Singh, J. Williams, and A. E. Hardman, “The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease,” Thorax, vol. 54, no. 3, pp. 213–222, 1999. View at Google Scholar · View at Scopus
  35. R. Aalbers, J. Ayres, V. Backer et al., “Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial,” European Respiratory Journal, vol. 19, no. 5, pp. 936–943, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Wadbo, C. G. Löfdahl, K. Larsson et al., “Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study,” European Respiratory Journal, vol. 20, no. 5, pp. 1138–1146, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Sukisaki, H. Senjyu, K. Oishi, N. Rikitomi, and K. Ariyoshi, “Single dose of inhaled procaterol has a prolonged effect on exercise performance of patients with COPD,” Physiotherapy Theory and Practice, vol. 24, no. 4, pp. 255–263, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. R. A. Stockley, N. Chopra, and L. Rice, “Addition of salmeterol to existing treatment in patients with COPD: a 12 month study,” Thorax, vol. 61, no. 2, pp. 122–128, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Verkindre, F. Bart, B. Aguilaniu et al., “The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease,” Respiration, vol. 73, no. 4, pp. 420–427, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. M. A. Puhan, D. Chandra, Z. Mosenifar et al., “The minimal important difference of exercise tests in severe COPD,” European Respiratory Journal, vol. 37, no. 4, pp. 784–790, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. E. R. Sutherland and B. J. Make, “Maximum exercise as an outcome in COPD: minimal clinically important difference,” Journal of Chronic Obstructive Pulmonary Disease, vol. 2, no. 1, pp. 137–141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. S. J. Singh, P. W. Jones, R. Evans, and M. D. L. Morgan, “Minimum clinically important improvement for the incremental shuttle walking test,” Thorax, vol. 63, no. 9, pp. 775–777, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Casaburi, “Factors determining constant work rate exercise tolerance in COPD and their role in dictating the minimal clinically important difference in response to interventions,” Journal of Chronic Obstructive Pulmonary Disease, vol. 2, no. 1, pp. 131–136, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. M. A. Puhan, M. J. Mador, U. Held, R. Goldstein, G. H. Guyatt, and H. J. Schünemann, “Interpretation of treatment changes in 6-minute walk distance in patients with COPD,” European Respiratory Journal, vol. 32, no. 3, pp. 637–643, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Cambach, R. V. M. Chadwick-Straver, R. C. Wagenaar, A. R. J. Van Keimpema, and H. C. G. Kemper, “The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial,” European Respiratory Journal, vol. 10, pp. 104–113, 1997. View at Google Scholar · View at Scopus
  46. K. C. Ong, W. F. Chong, C. Soh, and A. Earnest, “Comparison of different exercise tests in assessing outcomes of pulmonary rehabilitation,” Respiratory Care, vol. 49, no. 12, pp. 1498–1503, 2004. View at Google Scholar · View at Scopus
  47. D. E. O'Donnell, M. McGuire, L. Samis, and K. A. Webb, “General exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitation,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 5, pp. 1489–1497, 1998. View at Google Scholar · View at Scopus
  48. J. Porszasz, M. Emtner, S. Goto, A. Somfay, B. J. Whipp, and R. Casaburi, “Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD,” Chest, vol. 128, no. 4, pp. 2025–2034, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. D. E. O'Donnell, N. Voduc, M. Fitzpatrick, and K. A. Webb, “Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 24, no. 1, pp. 86–94, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Maltais, A. Hamilton, D. Marciniuk et al., “Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD,” Chest, vol. 128, no. 3, pp. 1168–1178, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. D. E. O'Donnell, F. Sciurba, B. Celli et al., “Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD,” Chest, vol. 130, no. 3, pp. 647–656, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. F. Maltais, B. Celli, R. Casaburi et al., “Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD,” Respiratory Medicine, vol. 105, no. 4, pp. 580–587, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. D. E. O'Donnell, R. Casaburi, W. Vincken et al., “Effect of indacaterol on exercise endurance and lung hyperinflation in COPD,” Respiratory Medicine, vol. 105, no. 7, pp. 1030–1036, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Oga, K. Nishimura, M. Tsukino, S. Sato, T. Hajiro, and M. Mishima, “A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD,” Chest, vol. 123, no. 6, pp. 1810–1816, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. J. A. Neder, J. P. Fuld, T. Overend et al., “Effects of formoterol on exercise tolerance in severely disabled patients with COPD,” Respiratory Medicine, vol. 101, no. 10, pp. 2056–2064, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Travers, P. Laveneziana, K. A. Webb, S. Kesten, and D. E. O'Donnell, “Effect of tiotropium bromide on the cardiovascular response to exercise in COPD,” Respiratory Medicine, vol. 101, no. 9, pp. 2017–2024, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. W. D. C. Man, N. Mustfa, D. Nikoletou et al., “Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD,” Thorax, vol. 59, no. 6, pp. 471–476, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Aliverti, K. Rodger, R. L. Dellacà et al., “Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD,” Thorax, vol. 60, no. 11, pp. 916–924, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. M. M. Peters, K. A. Webb, and D. E. O'Donnell, “Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD,” Thorax, vol. 61, no. 7, pp. 559–567, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. B. J. Whipp and S. A. Ward, “Quantifying intervention-related improvements in exercise tolerance,” European Respiratory Journal, vol. 33, no. 6, pp. 1254–1260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. T. E. Dolmage, R. A. Evans, K. Hill, M. Blouin, D. Brooks, and R. S. Goldstein, “The effect of pulmonary rehabilitation on critical walk speed in patients with COPD: a comparison with self-paced walks,” Chest, vol. 141, pp. 413–419, 2012. View at Google Scholar
  62. T. Eaton, P. Young, K. Nicol, and J. Kolbe, “The endurance shuttle walking test: a responsive measure in pulmonary rehabilitation for COPD patients,” Chronic Respiratory Disease, vol. 3, no. 1, pp. 3–9, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Brouillard, V. Pepin, J. Milot, Y. Lacasse, and F. Maltais, “Endurance shuttle walking test: responsiveness to salmeterol in COPD,” European Respiratory Journal, vol. 31, no. 3, pp. 579–584, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. M. E. Bédard, C. Brouillard, V. Pepin et al., “Tiotropium improves walking endurance in COPD,” European Respiratory Journal, vol. 39, pp. 265–271, 2012. View at Google Scholar
  65. F. Pitta, T. Troosters, M. A. Spruit, V. S. Probst, M. Decramer, and R. Gosselink, “Characteristics of physical activities in daily life in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 9, pp. 972–977, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. C. B. Cooper, M. Abrazado, D. Legg, and S. Kesten, “Development and implementation of treadmill exercise testing protocols in COPD,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 5, pp. 375–385, 2010. View at Google Scholar · View at Scopus
  67. F. Sava, H. Perrault, C. Brouillard et al., “Detecting improvements in dyspnea in COPD using a three-minute constant rate shuttle walking protocol,” Journal of Chronic Obstructive Pulmonary Disease, vol. 9, pp. 395–400, 2012. View at Google Scholar
  68. Y. Lacasse, E. Wong, G. H. Guyatt, D. King, D. J. Cook, and R. S. Goldstein, “Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease,” Lancet, vol. 348, no. 9035, pp. 1115–1119, 1996. View at Publisher · View at Google Scholar · View at Scopus
  69. A. E. Holland, C. J. Hill, T. Rasekaba, A. Lee, M. T. Naughton, and C. F. McDonald, “Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease,” Archives of Physical Medicine and Rehabilitation, vol. 91, no. 2, pp. 221–225, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Satake, H. Takahashi, K. Sugawara et al., “Inhibitory effect of procaterol on exercise dynamic lung hyperinflation during the 6-min walk test in stable patients with chronic obstructive pulmonary disease,” Arzneimittel-Forschung/Drug Research, vol. 61, no. 1, pp. 8–13, 2011. View at Google Scholar · View at Scopus
  71. T. Shioya, M. Satake, K. Sato et al., “Long-term effect of the β2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease: clinical study with special reference to health-related quality of life and activities of daily living,” Arzneimittel-Forschung/Drug Research, vol. 58, no. 1, pp. 24–28, 2008. View at Google Scholar · View at Scopus
  72. M. Cazzola, G. L. Biscione, F. Pasqua et al., “Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD,” Respiratory Medicine, vol. 102, no. 10, pp. 1425–1430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Boyd, A. H. Morice, J. C. Pounsford, M. Siebert, N. Peslis, and C. Crawford, “An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD),” European Respiratory Journal, vol. 10, pp. 815–821, 1997. View at Publisher · View at Google Scholar · View at Scopus
  74. P. Weiner, R. Magadle, N. Berar-Yanay, A. Davidovich, and M. Weiner, “The cumulative effect of long-acting bronchodilators, exercise, and inspiratory muscle training on the perception of dyspnea patients with advanced COPD,” Chest, vol. 118, no. 3, pp. 672–678, 2000. View at Google Scholar · View at Scopus
  75. N. Okudan, M. Gök, H. Gökbel, and M. Süerdem, “Single dose of tiotropium improves the 6-minute walk distance in chronic obstructive pulmonary disease,” Lung, vol. 184, no. 4, pp. 201–204, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. V. Pepin, J. Brodeur, Y. Lacasse et al., “Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease,” Thorax, vol. 62, no. 4, pp. 291–298, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. P. L. Paggiaro, R. Dahle, I. Bakran, L. Frith, K. Hollingworth, and J. Efthimiou, “Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease,” Lancet, vol. 351, no. 9105, pp. 773–780, 1998. View at Publisher · View at Google Scholar · View at Scopus
  78. G. J. Criner, F. C. Cordova, S. Furukawa et al., “Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 6, pp. 2018–2027, 1999. View at Google Scholar · View at Scopus
  79. R. M. Leach, A. C. Davidson, S. Chinn, C. H. C. Twort, I. R. Cameron, and N. T. Bateman, “Portable liquid oxygen and exercise ability in severe respiratory disability,” Thorax, vol. 47, no. 10, pp. 781–789, 1992. View at Google Scholar · View at Scopus
  80. American Thoracic Society, “ATS statement: guidelines for the six-minute walk test,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 1, pp. 111–117, 2002. View at Google Scholar · View at Scopus
  81. T. Troosters, J. Vilaro, R. Rabinovich et al., “Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 20, no. 3, pp. 564–569, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. B. Borel, C. Fabre, S. Saison, F. Bart, and J. M. Grosbois, “An original field evaluation test for chronic obstructive pulmonary disease population: the six-minute stepper test,” Clinical Rehabilitation, vol. 24, no. 1, pp. 82–93, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. B. Rammaert, S. Leroy, B. Cavestri, B. Wallaert, and J. M. Grosbois, “Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis,” Revue des Maladies Respiratoires, vol. 28, pp. e52–e57, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. R. Casaburi, “Physiologic responses to training,” Clinics in Chest Medicine, vol. 15, no. 2, pp. 215–227, 1994. View at Google Scholar · View at Scopus
  85. R. Casaburi and R. Zuwallack, “Pulmonary rehabilitation for management of chronic obstructive pulmonary disease,” The New England Journal of Medicine, vol. 360, no. 13, pp. 1282–1335, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. R. Casaburi, A. Patessio, F. Ioli, S. Zanaboni, C. F. Donner, and K. Wasserman, “Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease,” American Review of Respiratory Disease, vol. 143, no. 1, pp. 9–18, 1991. View at Google Scholar · View at Scopus
  87. F. Maltais, P. Leblanc, C. Simard et al., “Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 2, pp. 442–447, 1996. View at Google Scholar · View at Scopus
  88. M. J. Mador, T. J. Kufel, L. A. Pineda et al., “Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 4, pp. 930–935, 2001. View at Google Scholar · View at Scopus
  89. R. Casaburi, J. Porszasz, M. R. Burns, E. R. Carithers, R. S. Y. Chang, and C. B. Cooper, “Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 5, pp. 1541–1551, 1997. View at Google Scholar · View at Scopus
  90. F. Maltais, P. Leblanc, J. Jobin et al., “Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 2, pp. 555–561, 1997. View at Google Scholar · View at Scopus
  91. P. Gagnon, J. S. Bussieres, F. Ribeiro et al., “Influences of spinal anesthesia on exercise tolerance in patients with COPD,” American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 7, pp. 606–615, 2012. View at Google Scholar
  92. F. Gigliotti, C. Coli, R. Bianchi et al., “Exercise training improves exertional dyspnea in patients with COPD: evidence of the role of mechanical factors,” Chest, vol. 123, no. 6, pp. 1794–1802, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. D. E. O'Donnell, S. M. Revill, and K. A. Webb, “Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 5, pp. 770–777, 2001. View at Google Scholar · View at Scopus
  94. D. E. O'Donnell, M. Lam, and K. A. Webb, “Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 2, pp. 542–549, 1999. View at Google Scholar · View at Scopus
  95. D. E. O'Donnell, A. L. Hamilton, and K. A. Webb, “Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD,” Journal of Applied Physiology, vol. 101, no. 4, pp. 1025–1035, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. D. Saey, R. Debigaré, P. LeBlanc et al., “Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 4, pp. 425–430, 2003. View at Publisher · View at Google Scholar · View at Scopus
  97. D. Deschênes, V. Pepin, D. Saey, P. LeBlanc, and F. Maltais, “Locus of symptom limitation and exercise response to bronchodilation in chronic obstructive pulmonary disease,” Journal of Cardiopulmonary Rehabilitation and Prevention, vol. 28, no. 3, pp. 208–214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. A. Cockcroft, A. Beaumont, L. Adams, and A. Guz, “Arterial oxygen desaturation during treadmill and bicycle exercise in patients with chronic obstructive airways disease,” Clinical Science, vol. 68, no. 3, pp. 327–332, 1985. View at Google Scholar · View at Scopus
  99. P. Palange, S. Forte, P. Onorati, F. Manfredi, P. Serra, and S. Carlone, “Ventilatory and metabolic adaptations to walking and cycling in patients with COPD,” Journal of Applied Physiology, vol. 88, pp. 1715–1720, 2000. View at Google Scholar
  100. M. Poulain, F. Durand, B. Palomba et al., “6-Minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD,” Chest, vol. 123, no. 5, pp. 1401–1407, 2003. View at Publisher · View at Google Scholar · View at Scopus